AIM Rule 26
The following information is disclosed in accordance with Rule 26 of the AIM Rules for Companies (February 2010).
Company Information
Business Description
Please follow this link for a description of the business.
Incorporation and Operation
Lupus Capital plc is incorporated in England and Wales (registration number 2806007) and its principal countries of operation are the United Kingdom and the United States of America.
Please follow this link for a copy of the Company's Articles of Association.
Directors
Please follow this link for the names of the Directors and their biographies.
Corporate governance and internal controls
Please follow this link for details of the responsibilities of the Board and corporate governance committees.
Securities Information
Exchanges and Platforms
Lupus Capital plc’s ordinary shares are admitted to trading on AIM, a marketplace regulated by the London Stock Exchange.
Securities in Issue (as at 31 May 2010)
Total number of ordinary shares in issue - 137,211,533, of which 7,446,683 are held in Treasury. The Company’s voting ordinary share capital is therefore 129,840,798 shares.
Securities not in Public Hands (as at 31 May 2010)
So far as the Company is aware, percentage of Lupus Capital plc’s ordinary shares that are not in public hands is 45.1%.
Significant Shareholders (as notified to the Company at 31 May 2010)
| Aviva | 19,928,945 | 15.35% |
| F & C Asset Management | 16,158,580 | 12.44% |
| G Hutchings esq. and Associated Entities | 14,300,417 | 11.01% |
| Polar Capital | 8,886,077 | 6.84% |
| Schroder Asset Management | 8,116,454 | 6.25% |
| SISU Capital | 5,206,366 | 4.01% |
| EPIC | 4,261,791 | 3.28% |
Restrictions on Transfer
There are currently no restrictions on the transfer of securities.
Documentation and Announcements
Admission Document
Please follow this link to access the AIM admission document.
Shareholder Circulars
Please follow this link to access all circulars and similar publications sent to shareholders within the past 12 months.
Reports
Please follow this link to access the most recent annual report and accounts and all interim reports published since the last annual report.
Regulatory Announcements
Please follow this link to access all notifications made it the past 12 months.
Advisers
Please follow this link for details of Lupus Capital's NOMAD and other key advisers.
AIM Rule 26 Information last updated on 31 May 2010